Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
10,162,129
-
Shares change
-
+2,615,480
-
Total reported value, excl. options
-
$101,447,473
-
Value change
-
+$27,185,983
-
Put/Call ratio
-
28.02%
-
Number of buys
-
57
-
Number of sells
-
-29
-
Price
-
$9.99
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q2 2020
106 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q2 2020.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,162,129 shares
of 27,407,170 outstanding shares and own 37.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,382,136 shares), VANGUARD GROUP INC (943,652 shares), G2 Investment Partners Management LLC (814,716 shares), Parkman Healthcare Partners LLC (725,590 shares), FEDERATED HERMES, INC. (649,553 shares), RENAISSANCE TECHNOLOGIES LLC (557,370 shares), Fairpointe Capital LLC (323,276 shares), Russell Investments Group, Ltd. (321,925 shares), Ikarian Capital, LLC (312,268 shares), and EAM Investors, LLC (304,636 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.